Viekira XR Interactions
There are 719 drugs known to interact with Viekira XR (dasabuvir/ombitasvir/paritaprevir/ritonavir), along with 9 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 276 are major, 402 are moderate, and 41 are minor.
- View all 719 medications that may interact with Viekira XR
- View Viekira XR alcohol/food interactions (3)
- View Viekira XR disease interactions (9)
Most frequently checked interactions
View interaction reports for Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir) and the medicines listed below.
- Adasuve (loxapine)
- Advate (antihemophilic factor)
- Afinitor (everolimus)
- Aldurazyme (laronidase)
- amitriptyline
- Bosulif (bosutinib)
- Corifact (factor XIII)
- Daklinza (daclatasvir)
- Enbrel (etanercept)
- Esbriet (pirfenidone)
- Gleevec (imatinib)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Moderiba (ribavirin)
- Ofev (nintedanib)
- Orkambi (ivacaftor / lumacaftor)
- Parsabiv (etelcalcetide)
- Placidyl (ethchlorvynol)
- Prolia (denosumab)
- Recombinate (antihemophilic factor)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Synagis (palivizumab)
- Tecfidera (dimethyl fumarate)
- Trizivir (abacavir / lamivudine / zidovudine)
- Truvada (emtricitabine / tenofovir disoproxil)
- Valium (diazepam)
- Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
- Votrient (pazopanib)
Viekira XR alcohol/food interactions
There are 3 alcohol/food interactions with Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir).
Viekira XR disease interactions
There are 9 disease interactions with Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir) which include:
- cirrhosis
- liver impairment
- immunosuppression
- hepatic dysfunction
- hemophilia
- hyperglycemia
- hyperlipidemia
- heart block
- hepatotoxicity
Report options
More about Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viekira XR consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir (Mavyret) is an oral combination medicine containing fixed doses of 2 ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.